Delivery Order SPE2DB22D1017-SPE2DB25FF9CR
Award Date
4/1/25
Potential Completion Date
4/2/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,806.19 delivery order is for Candesartan Cilexetil 16 mg tablets, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of October 28, 2024 and utilizes a firm fixed-price pricing structure. This award is associated with a larger Indefinite Delivery...
This federal contract award, valued at $12,657.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Candesartan Cilexetil 32 mg tablets, a medication used to treat high blood pressure and heart failure. The contract is not designated as a set-aside and has an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Candesartan Cilexetil 16 mg tablets, a medication used to treat high blood pressure and heart failure. The contract has a ceiling value of $1,787.82 and a completion date of April 22, 2025. This contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Candesartan Cilexetil 32 mg tablets. The contract has a ceiling value of $3,720.60 and is a firm fixed-price delivery order with a completion date of May 29, 2025. The contract is not set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets, a cardiovascular medication, with a ceiling value of $15,110.00. It is a firm fixed price, delivery order contract with a completion date of January 14, 2025. The contract is not designated under any set-aside program. AmerisourceBergen holds a...
This federal contract award, valued at $2,126.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets, a medication used to treat...
This federal contract award, valued at $1,589.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets, a cardiovascular medication, to support military healthcare programs. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Candesartan Cilexetil 32 mg tablets, a medication used to treat high blood pressure and heart failure. The total ceiling value of the contract is $8,333.90, and it has a period of performance through December 17, 2024. The contract is a firm-fixed price delivery order and does not...
This federal contract award, valued at $9,959.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets, a cardiovascular medication, with a performance period through October 31, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $5,534.12 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 8 mg tablets, a medication used to treat high blood pressure and heart failure. The award falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...